Menopause Clinical Trials

This study is to compare the efficacy of study drug, Enobosarm, administered once daily to that of placebo by evaluating the number of subject reported stress incontinence episodes per day.

Are you a woman experiencing menopause? If so you may be experiencing one or more of the unpleasant symptoms that come with this experience. These are the symptoms of menopause that pharmaceutical companies are trying to find treatments for. Horizons Clinical Research Center, LLC often conducts studies for these new ...

A Study to Evaluate the Efficacy and Safety of Ospemifene in Patients with Moderate to Severe Vaginal Dryness, a Symptom of Vulvo-vaginal Atrophy (VVA) due to Menopause.

Twelve week study of an estrogen vaginal suppository, six visits, to assess its impact on vaginal dryness and pain in menopausal women.

Vaginal atrophy, also called (Vaginal Dryness/Irritation/Painful Intercourse), is thinning, drying and inflammation of the vaginal walls due to your body having less estrogen. Vaginal atrophy occurs most often after menopause. For many women, vaginal atrophy makes intercourse painful — and if intercourse hurts, your interest in sex will naturally decrease. ...

Currently we have the following studies: Birth Control/ Contraceptive Vaginal Atrophy Pain During Intercourse Dysplasia Endometriosis Pap Smear Mammogram Bone Density Osteoporosis Nocturia Uterine Fibroids Uterine Bleeding Post Menopausal Studies HPV STD Hot Flashes

Diablo Clinical Research is conducting a clinical research study to evaluate an investigational medication in postmenopausal women to see its effect on cholesterol. You may qualify for the study if you are: A woman Post menopausal In good general health Not using hormone therapy Qualified participants may receive at no ...

Tired of Suffering from Hot Flashes & Sweating caused by Menopause?  

Feeling Hot Flashes from Menopause? Don’t Want Hormones? Want to Try a New, Non-hormonal Treatment to “Beat the Heat”? We’re enrolling volunteers in a study of an investigational, non-hormonal medication to decrease menopause symptoms. If you are interested in participating in our Hot Flash study, please fill out the form ...

Framed within a diathesis-stress model, the primary objective of this research is to determine the pathophysiological mechanisms of estradiol (E2) in the clinical anxiety and anhedonia seen in the menopause transition (MT). Specifically whether E2 variability or E2 levels predict exaggerated hypothalamic-pituitary-adrenal (HPA) axis reactivity and impaired recovery to stress ...